Delivery Order SPE2DB20D3101-SPE2DB23FRRC0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $2,014.59 firm fixed price delivery order is for the supply of 4,564,147,104 units of the drug Tadalafil 20 mg tablets in 30-count packages. The award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,199.21 firm fixed-price delivery order is for the supply of 4,566,676,182 units of Tadalafil 5 mg tablets. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,075,614 units of Tadalafil 20 mg tablets in 60-count packages, with a total ceiling value of $26,692.81. The contract is a Firm Fixed Price Delivery Order with a completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $155,346.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563829008 Tadalafil 20 mg tablets in 30-count packaging. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,509.71, is for the delivery of tadalafil 20 mg tablets. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 1, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $52,127.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,566,929,547 units of Tadalafil 20 mg Tablets, a medication used to treat various medical conditions. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 15, 2025. This award is not designated as a set-aside contract....
- This federal contract award, valued at $6,077.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,975,200 tablets of tadalafil 10 mg, a medication used to treat various medical conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 21, 2025. It is not designated as a set-aside...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,752 units of 60-count bottles of Tadalafil 20 mg tablets. The $42,785.57 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 1, 2025. The contract does not have a set-aside designation, indicating open competition. In addition to this delivery order, Amerisourcebergen holds a...
- This federal contract award, valued at $32,954.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,850 units of Tadalafil 20 mg tablets, a medication used to treat various medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award, valued at $3,274.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract delivers Tadalafil 20mg tablets, a prescription medication used to treat various medical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRRC0Delivery Order
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRRC0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,448.04 firm fixed-price delivery order is for the supply of 4,561,423,129 units of Tadalafil 20 mg tablets, with a completion date of July 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/6/23 |